Literature DB >> 18680243

Cerebral venous thrombosis and heparin-induced thrombocytopenia in an 18-year old male with severe ulcerative colitis.

Gudrun Scheving Thorsteinsson1, Maria Magnussson, Lena M Hallberg, Nils Gunnar Wahlgren, Fredrik Lindgren, Petter Malmborg, Thomas H Casswall.   

Abstract

The risk of thromboembolism is increased in inflammatory bowel disease and its symptoms may be overlooked. Furthermore, its treatment can be complex and is not without complications. We describe a case of an adolescent boy who developed a cerebral sinus venous thrombosis during a relapse of his ulcerative colitis and who, while on treatment with heparin, developed heparin-induced thrombocytopenia (HIT). The treatment was then switched to fondaparinux, a synthetic and selective inhibitor of activated factor X.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18680243      PMCID: PMC2731290          DOI: 10.3748/wjg.14.4576

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  26 in total

Review 1.  Haemorrhagic cerebral sinus thrombosis associated with ulcerative colitis: a case report of successful treatment by anticoagulant therapy.

Authors:  T Tsujikawa; M Urabe; H Bamba; A Andoh; M Sasaki; S Koyama; Y Fujiyama; T Bamba
Journal:  J Gastroenterol Hepatol       Date:  2000-06       Impact factor: 4.029

Review 2.  Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.

Authors:  L Sutherland; J K Macdonald
Journal:  Cochrane Database Syst Rev       Date:  2006-04-19

Review 3.  Immunosuppressive drugs in ulcerative colitis: twisting facts to suit theories?

Authors:  B E Sands
Journal:  Gut       Date:  2006-04       Impact factor: 23.059

Review 4.  Cerebral sinus thrombosis in patients with inflammatory bowel disease: a case report.

Authors:  Hasan Umit; Talip Asil; Yahya Celik; Ahmet Tezel; Gulbin Dokmeci; Nermin Tuncbilek; Ufuk Utku; Ali-Riza Soylu
Journal:  World J Gastroenterol       Date:  2005-09-14       Impact factor: 5.742

5.  Cerebral venous and sinus thrombosis: patients with a fatal outcome during intravenous dose-adjusted heparin treatment.

Authors:  F Masuhr; S Mehraein
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

6.  The role of surface PF4: glycosaminoglycan complexes in the pathogenesis of heparin-induced thrombocytopenia (HIT).

Authors:  Mortimer Poncz; Lubica Rauova; Douglas B Cines
Journal:  Pathophysiol Haemost Thromb       Date:  2006

Review 7.  Diagnosis and treatment of heparin-induced thrombocytopenia in neonates and children.

Authors:  Lorenz Risch; Andreas R Huber; Markus Schmugge
Journal:  Thromb Res       Date:  2005-02-09       Impact factor: 3.944

Review 8.  Inflammation and coagulation in inflammatory bowel disease: The clot thickens.

Authors:  Silvio Danese; Alfredo Papa; Simone Saibeni; Alessandro Repici; Alberto Malesci; Maurizio Vecchi
Journal:  Am J Gastroenterol       Date:  2006-11-13       Impact factor: 10.864

9.  Heparin-induced thrombocytopenia from venous thromboembolism treatment.

Authors:  S M Begelman; M J Hursting; R V Aghababian; D McCollum
Journal:  J Intern Med       Date:  2005-12       Impact factor: 8.989

Review 10.  Prothrombotic abnormalities in childhood ischaemic stroke.

Authors:  Chris Barnes; Gabrielle Deveber
Journal:  Thromb Res       Date:  2005-07-21       Impact factor: 3.944

View more
  9 in total

1.  [Diagnostic and treatment recommendations from the FACME ad-hoc expert working group on the management of cerebral venous sinus thrombosis associated with COVID-19 vaccination].

Authors: 
Journal:  Neurologia       Date:  2021-05-06       Impact factor: 3.109

Review 2.  Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitis.

Authors:  Nilesh Chande; Yongjun Wang; John Wd McDonald; John K MacDonald
Journal:  Cochrane Database Syst Rev       Date:  2015-08-05

3.  Cerebrovascular Events in Pediatric Inflammatory Bowel Disease: A Review of Published Cases.

Authors:  Pejman Rohani; Nazanin Taraghikhah; Mohammad Mehdi Nasehi; Hosein Alimadadi; Hamid Assadzadeh Aghdaei
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2022-05-09

4.  Successful endovascular therapy for cerebral venous sinus thrombosis accompanied by heparin-induced thrombocytopenia.

Authors:  Yoshihisa Fukushima; Kenji Takahashi; Ichiro Nakahara
Journal:  Interv Neuroradiol       Date:  2020-03-01       Impact factor: 1.610

5.  HITT or Miss.

Authors:  Michael Kinney; Thomas Peukert; Stephen McKinstry; Gary Benson; Paul McMonagle
Journal:  Ulster Med J       Date:  2013-09

6.  Cyclosporine-A-Induced Intracranial Thrombotic Complications: Systematic Review and Cases Report.

Authors:  Si-Ying Song; Zhong-Ao Wang; Yu-Chuan Ding; Xun-Ming Ji; Ran Meng
Journal:  Front Neurol       Date:  2021-02-11       Impact factor: 4.003

7.  Diagnostic and treatment recommendations from the FACME ad-hoc expert working group on the management of cerebral venous sinus thrombosis associated with COVID-19 vaccination.

Authors: 
Journal:  Neurologia (Engl Ed)       Date:  2021-05-29

8.  [Diagnostic and treatment recommendations from the FACME ad-hoc expert working group on the management of cerebral venous sinus thrombosis associated with COVID-19 vaccination].

Authors: 
Journal:  Neurologia       Date:  2021-05-06       Impact factor: 3.109

9.  Cerebral Venous Thrombosis following COVID-19 Vaccination.

Authors:  Chia Siang Kow; Syed Shahzad Hasan
Journal:  J Stroke Cerebrovasc Dis       Date:  2021-05-10       Impact factor: 2.136

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.